Drug comparisons
Ertugliflozin vs Troglitazone
Compare Ertugliflozin (Steglatro, SGLT2i) vs Troglitazone (withdrawn TZD) for T2D. Safety, efficacy, availability differences explained.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when patients or clinicians review historical TZD options against current SGLT2 inhibitors for type 2 diabetes.
Bottom line
Ertugliflozin is a currently used SGLT2 inhibitor while Troglitazone is unavailable due to severe liver risks.
All medication comparisons